Effect of Acupotomy Modulation of NLRP3/Caspase-1/GSDMD Pathway on Chondrocyte Pyroptosis in Knee Osteoarthritis

针刺疗法调节NLRP3/Caspase-1/GSDMD通路对膝骨关节炎软骨细胞焦亡的影响

阅读:4

Abstract

BACKGROUND: Knee osteoarthritis (KOA) is a prevalent degenerative joint disease characterized by progressive cartilage degradation and inflammation, often leading to pain and reduced mobility. Current therapeutic approaches, including pharmacological and surgical interventions, provide symptomatic relief but rarely address the underlying pathological mechanisms effectively. Acupotomy therapy, a minimally invasive technique integrating traditional Chinese medicine and modern surgical concepts, has shown promise in alleviating KOA symptoms. However, its mechanisms, particularly concerning chondrocyte pyroptosis, remain underexplored. This study investigates the role of acupotomy therapy in modulating chondrocyte pyroptosis via the NLRP3/Caspase-1/GSDMD signaling pathway in a rabbit KOA model. METHODS: Forty New Zealand rabbits were randomized into four groups: control, model, acupotomy, and drug-treated groups. A KOA model was induced via intra-articular injection of papain. Interventions included acupotomy therapy and oral celecoxib. Outcomes were assessed using behavioral scoring, micro-CT imaging, histological staining, serum inflammatory markers (ELISA), and the expression of NLRP3 inflammasome-associated proteins (qPCR and Western blot). RESULTS: Acupotomy therapy significantly improved behavioral scores and reduced knee joint space narrowing. Histological analyses revealed improved cartilage integrity and decreased inflammatory markers. Expression levels of NLRP3, Caspase-1, ASC, and GSDMD were downregulated in the acupotomy group compared to the model group. CONCLUSION: This study highlights the therapeutic potential of acupotomy therapy in alleviating KOA symptoms and reducing chondrocyte pyroptosis by modulating the NLRP3 inflammasome pathway. These findings provide a mechanistic basis for its application in KOA treatment and a foundation for further clinical exploration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。